Mayo Clinic to Use Luminex's xMAP for Thalassemia Tests | GenomeWeb
NEW YORK (GenomeWeb News) - Mayo Clinic will provide genetic tests and other services using Luminex’s xMAP technology and will work with Luminex to develop testing for the blood disorder thalassemia under a new licensing and development collaboration, the company said today.
 
The program includes collaboration and licensing provisions for inherited thalassemia and allows for the development of additional tests as well, Luminex said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.